TTD | Drug: D0O8LK

Drug General Information
Drug ID	D0O8LK
Former ID	DNC007329
Drug Name	3-[12-(benzylmethylamino)dodecyloxy]xanthen-9-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528456]
Structure		Download 2D MOL 3D MOL
Formula	C33H41NO3
Canonical SMILES	CN(CCCCCCCCCCCCOC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3O2)CC4=CC<br />=CC=C4
InChI	1S/C33H41NO3/c1-34(26-27-17-11-10-12-18-27)23-15-8-6-4-2-3-5-7-9-16-24-36-28-21-22-30-32(25-28)37-31-20-14-13-19-29(31)33(30)35/h10-14,17-22,25H,2-9,15-16,23-24,26H2,1H3
InChIKey	JLVUWPGHBWDHKA-UHFFFAOYSA-N
PubChem Compound ID	16066832
Target and Pathway
Target(s)	Cholinesterase	Target Info	Inhibitor	[528456]
PANTHER Pathway	Muscarinic acetylcholine receptor 1 and 3 signaling pathway
	Muscarinic acetylcholine receptor 2 and 4 signaling pathway
	Nicotinic acetylcholine receptor signaling pathway
WikiPathways	Irinotecan Pathway
References
Ref 528456	Bioorg Med Chem. 2007 Jan 1;15(1):575-85. Epub 2006 Sep 27.Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.
Ref 528456	Bioorg Med Chem. 2007 Jan 1;15(1):575-85. Epub 2006 Sep 27.Cholinesterase inhibitors: SAR and enzyme inhibitory activity of 3-[omega-(benzylmethylamino)alkoxy]xanthen-9-ones.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information